End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.19 CNY | +1.35% | +3.02% | -7.35% |
24/04 | Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator | MT |
18/04 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Official Publications
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Official Publications